Fortrea Holdings Inc. reports news on its role as a global contract research organization serving the life sciences industry. The company provides phase I-IV clinical trial management, clinical pharmacology and consulting services for biopharmaceutical, biotechnology, medical device and diagnostic customers.
Recurring Fortrea updates include quarterly and annual financial results, book-to-bill trends, guidance, debt and capital actions, executive and board matters, equity award disclosures and technology used in clinical trial operations. Company announcements also cover platforms such as Fortrea Intelligent Technology and Xcellerate, which support trial workflow, oversight and site-facing processes.
Rhea-AI Summary
Summary not available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.32%
Tags
FAQ
What is the current stock price of Fortrea Holdings (FTRE)?
Fortrea Holdings (FTRE) last closed at $22.78.
What is the market cap of Fortrea Holdings (FTRE)?
The market cap of Fortrea Holdings (FTRE) is approximately $2.2B.